Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis, high-throughput screening and pharmacological characterization of β-lactam derivatives as TRPM8 antagonists

  • Torre-Martínez, Roberto de la
  • Bonache de Marcos, María Ángeles
  • Llabrés-Campaner, P. J.
  • Balsera, Beatriz
  • Fernández-Carvajal, Asia
  • Fernández-Ballester, Gregorio
  • Pérez de Vega, M. Jesús
  • González-Muñiz, Rosario
The mammalian transient receptor potential melastatin channel 8 (TRPM8), highly expressed in trigeminal and dorsal root ganglia, mediates the cooling sensation and plays an important role in the cold hypersensitivity characteristic of some types of neuropathic pain, as well as in cancer. Consequently, the identification of selective and potent ligands for TRPM8 is of great interest. Here, a series of compounds, having a β-lactam central scaffold, were prepared to explore the pharmacophore requirements for TRPM8 modulation. Structure-activity studies indicate that the minimal requirements for potent β-lactam-based TRPM8 blockers are hydrophobic groups (benzyl preferentially or Bu) on R, R, R and R and a short N-alkyl chain (≤3 carbons). The best compounds in the focused library (41 and 45) showed IC values of 46 nM and 83 nM, respectively, in electrophysiology assays. These compounds selectively blocked all modalities of TRPM8 activation, i.e. menthol, voltage, and temperature. Molecular modelling studies using a homology model of TRPM8 identified two putative binding sites, involving networks of hydrophobic interactions, and suggesting a negative allosteric modulation through the stabilization of the closed state. Thus, these β-lactams provide a novel pharmacophore scaffold to evolve TRPM8 allosteric modulators to treat TRPM8 channel dysfunction., We thank the Ministry of Economy and Competitiveness (BES-2010-037112, BFU 2012-39092-C02, BFU2015- 70067-REDC, SAF2015-66275-C2-R), and the Generalitat Valenciana (PROMETEO II/2014/011) for financial support. We express our gratitude to Jessy Medina for technical assistance, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disrupting vegf-vegfr1 interaction: De novo designed linear helical peptides to mimic the VEGF13-25 Fragment

  • Balsera, Beatriz
  • Bonache de Marcos, María Ángeles
  • Reille-Seroussi, Marie
  • Gagey-Eilstein, Nathalie
  • Vidal, Michel
  • González-Muñiz, Rosario
  • Pérez de Vega, M. Jesús
The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has important implications in angiogenesis and cancer, which moved us to search for peptide derivatives able to block this protein-protein interaction. In a previous work we had described a collection of linear 13-mer peptides specially designed to adopt helical conformations (Ac-SSEEXARNXAAXN-NH), as well as the evaluation of seven library components for the inhibition of the interaction of VEGF with its Receptor 1 (VEGFR1). This study led to the discovery of some new, quite potent inhibitors of this protein-protein system. The results we found prompted us to extend the study to other peptides of the library. We describe here the evaluation of a new selection of peptides from the initial library that allow us to identify new VEGF-VEGFR1 inhibitors. Among them, the peptide sequence containing F,W, and I residues at the 5, 9, and 12 positions, show a very significant nanomolar IC50 value, competing with VEGF for its receptor 1, VEGFR1 (Flt-1), which could represent a new tool within the therapeutic arsenal for cancer detection and therapy., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO) SAF2015-66275-C2-R, subprograma NEF and by the University Paris Descartes and the ANR (Grants ANR-2010-BLANC-1533-03). BBP thanks the CSIC for a predoctoral fellowship (JAE-Predoc from Junta para la Ampliación de Estudios, co-financed by FSE)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of α7 nicotinic receptors with analgesic activity

  • Balsera, Beatriz
  • Mulet, José
  • Sala, Salvador
  • Sala, Francisco
  • Torre-Martínez, Roberto de la
  • González-Rodríguez, Sara
  • Plata, Adrián
  • Naesens, L.
  • Fernández-Carvajal, Asia
  • Ferrer-Montiel, Antonio
  • Criado Herrero, Manuel
  • Pérez de Vega, M. Jesús
  • González-Muñiz, Rosario
α7 Nicotinic acetylcholine receptors (nAChRs) are ion channels implicated in a number of CNS pathological processes, including pain and psychiatric, cognitive and inflammatory diseases. Comparing with orthosteric agonism, positive allosteric modulation of these channels constitutes an interesting approach to achieve selectivity versus other nicotinic receptors. We have recently described new chalcones and 1,3-diphenylpropanones as positive allosteric modulators (PAMs) of α7 nAChRs, which proved to have good analgesic activities but poor pharmacokinetic properties. Here we report the preparation of amino acid and peptide derivatives as prodrugs of these modulators with the aim of improving their in vivo biological activity. While the valine derivative showed very short half life in aqueous solutions to be considered a prodrug, Val-Val and Val-Pro-Val are suitable precursors of the parent 1,3-diphenylpropanones, via chemical and enzymatic transformation, respectively. Compounds 19 (Val-Val) and 21 (Val-Pro-Val), prodrugs of the 2′,5′,4-trihydroxy-1,3-diphenylpropan-1-one 3, showed significant antinociceptive activity in in vivo assays. The best compound, 21, displayed a better profile in the analgesia test than its parent compound 3, exhibiting about the same potency but long-lasting effects., Funding: This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO) SAF2011-22802, BFU2015- 70067-REDC and SAF2015-66275-C2-R, and the Generalitat Valenciana, PROMETEO/2014/011. BBP thanks the CSIC for a predoctoral fellowship (JAE-Predoc from Junta para la Ampliación de Estudios, co-financed by FSE)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Recent progress in non-opioid analgesic peptides

  • Pérez de Vega, M. Jesús
  • Ferrer-Montiel, Antonio
  • González-Muñiz, Rosario
Pain is a prevalent complex medical problem, characterized by physically debilitating and mentally destabilizing conditions. Current pain therapeutics mainly include non-steroidal anti-inflammatory drugs and narcotics (opioids), but they exhibit limitations in efficacy, unwanted side effects and the problem of drug abuse. To overcome these issues, the discovery of different molecular players within pain pathways could lead to new opportunities for therapeutic intervention. Among other strategies, peptides could be powerful pharmaceutical agents for effective opioid-free medications for pain treatment. This review is a compendium of representative non-opioid analgesic peptides acting directly or indirectly at different ion channels and receptors distributed in nociceptive pathways. They include peptides targeting Ca, Na and K voltage-gated ion channels, the neuronal nicotinic receptors (nAChR), transient receptor potential channels (TRP), and different non-opioid G-protein coupled receptors (GPCRs), like the calcitonin gen-related peptide (CGRP), cannabinoid, bradykinin and neurotensin receptors, among others. Peptides engineered from protein-protein interactions among pain-related receptors and regulatory proteins also led to new therapeutic approaches for pain management. Following some successful examples, already in the clinics or under clinical trials, the improved understanding of pain mechanisms, and the advances in peptide permeation and/or delivery, could afford new analgesic peptides in the near future., This work was supported by the Spanish Ministry of Economy and Competitiveness [SAF 2015-66275-C2-R]; and Consejo Superior de Investigaciones Científicas, Spain (201580E073, 201880E109)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Small Library of Triazolyl Polyphenols Correlating Antioxidant Activity and Stability with Number and Position of Hydroxyl Groups

  • Bonache de Marcos, María Ángeles
  • Moreno-Fernández, Silvia
  • Miguel, Marta
  • Sabater-Muñoz, Beatriz
  • González-Muñiz, Rosario
Polyphenolic compounds have attracted much interest because of their antioxidant properties and multiple applications, from food or cosmetic preservatives to free radical scavengers as therapeutic agents. Inspired by common OH substitutions in natural products, here we describe a small library of 1,2,3-triazoles disubstituted with polyphenol groups at 1,4-positions, in an attempt to correlate the number and position of hydroxyl groups in the aromatic rings with the antioxidant activity. Some compounds from this library exhibit strong radical scavenging activities in the oxygen radical absorbance capacity assay, similar to or even higher than resveratrol and other well-kwon flavonoids. The antioxidant activity for selected compounds was confirmed in vitro through the 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonate) test and in vivo by a Saccharomyces cerevisiae model organism assay. The activity depends on the number and position of the hydroxyl groups, with compounds bearing a 2″5″-hydroxyl substituents on the phenyl ring at position 4 showing the best antioxidant values. The presence of two quinone-forming phenolic groups at the same molecule is behind the instability of some of these compounds in aqueous media., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO) SAF2015-66275-C2- R and CSIC (201580E073, 201880E109)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Recent progress in TRPM8 modulation: an update

  • González-Muñiz, Rosario
  • Bonache de Marcos, María Ángeles
  • Martín-Escura, Cristina
  • Gómez-Monterrey, Isabel
The transient receptor potential melastatin subtype 8 (TRPM8) is a nonselective, multimodal ion channel, activated by low temperatures (<28 °C), pressure, and cooling compounds (menthol, icilin). Experimental evidences indicated a role of TRPM8 in cold thermal transduction, different life-threatening tumors, and other pathologies, including migraine, urinary tract dysfunction, dry eye disease, and obesity. Hence, the modulation of the TRPM8 channel could be essential in order to understand its implications in these pathologies and for therapeutic intervention. This short review will cover recent progress on the TRPM8 agonists and antagonists, describing newly reported chemotypes, and their application in the pharmacological characterization of TRPM8 in health and disease. The recently described structures of the TRPM8 channel alone or complexed with known agonists and PIP2 are also discussed., This research was funded by the Spanish Ministerio de Economía y Competitividad (MINECO-FEDER) SAF2015-66275-C2-R, Comunidad de Madrid (IND2017_BMD-7673) and CSIC (201880E109, 201980E030)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

1-(2′,5′-dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (RGM079): A positive allosteric modulator of α7 nicotinic receptors with analgesic and neuroprotective activity

  • Pérez de Vega, M. Jesús
  • Fernández-Mendívil, Cristina
  • Torre-Martínez, Roberto de la
  • González-Rodríguez, Sara
  • Mulet, José
  • Sala, Francisco
  • Sala, Salvador
  • Criado Herrero, Manuel
  • Moreno-Fernández, Silvia
  • Miguel, Marta
  • Fernández-Carvajal, Asia
  • Ferrer-Montiel, Antonio
  • López, Manuela G.
  • González-Muñiz, Rosario
Acetylcholine α7 nicotinic receptors are widely expressed in the brain, where they are involved in the central processing of pain as well as in neuropsychiatric, neurodegenerative, and inflammatory processes. Positive allosteric modulators (PAMs) show the advantage of allowing the selective regulation of different subtypes of acetylcholine receptors without directly interacting with the agonist binding site. Here, we report the preparation and biological activity of a fluoro-containing compound, 1-(2′,5′-dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (8, RGM079), that behaves as a potent PAM of the α7 receptors and has a balanced pharmacokinetic profile and antioxidant properties comparable or even higher than well-known natural polyphenols. In addition, compound RGM079 shows neuroprotective properties in Alzheimer's disease (AD)-toxicity related models. Thus, it causes a concentration-dependent neuroprotective effect against the toxicity induced by okadaic acid (OA) in the human neuroblastoma cell line SH-SY5Y. Similarly, in primary cultures of rat cortical neurons, RGM079 is able to restore the cellular viability after exposure to OA and amyloid peptide Aβ, with cell death almost completely prevented at 10 and 30 μM, respectively. Finally, compound RGM079 shows in vivo analgesic activity in the complete Freund's adjuvant (CFA)-induced paw inflammation model after intraperitoneal administration., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad (MINECO-FEDER) grant number SAF2015-66275-C2-R and RTI2018-097189-C2 to RGM and AFM, and RTI2018-095793-B-I00 to MGL, the Comunidad de Madrid/European Union Ref S2017/BMD-3827 to MGL and the CSIC, grant number 201980E030 to RGM.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Insights into synaptotagmin-1 CB2 domain as a putative target for new analgesic

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Insights into synaptotagmin-1 C2B domain as a putative target for new analgesic

  • Martín-Martínez, Mercedes
  • Butrón, D.
  • Zamora-Carreras, H.
  • Devesa, I.
  • Treviño, Miguel A.
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Bonache de Marcos, María Ángeles
  • Lagartera, L.
  • Ferrer-Montiel, Antonio
  • Jiménez, M. Angeles
  • González-Muñiz, Rosario
17th Iberian Peptide Meeting, Madrid, 5-7th February 2020, SAF2015-66275-C2-R, CTQ2017-84371-P, RTI2018-097189-C2, CSIC, 201880E109, 201980E030., Peer reviewed